Can macrocyclic trichothecenes trigger mitochondrial dysfunction, reactive oxygen species production, and apoptosis?

Macrocyclic trichothecenes are fungal toxins with substantial experimental cytotoxicity. For roridins and verrucarins, the proposed ROS–apoptosis effects are supported in selected preclinical models; mitochondrial dysfunction is biologically credible but less directly demonstrated for these specific congeners.

Clinical and experimental evidence

• Verrucarin J increased ROS dose-dependently in ovarian-cancer cells; at 10 nM, nearly 90% of surviving cells had high ROS.
• Roridin E increased ROS and apoptotic markers in B16 mouse melanoma cells. Glutathione scavenging attenuated cytotoxicity, supporting a ROS-associated contribution to cell death.
• In non-small-cell lung-cancer cells, verrucarin J increased cleaved caspase-3 and cleaved PARP—canonical execution-phase apoptosis markers—and reduced anti-apoptotic BCL-2 expression.
• Effects are not uniform across the chemical family: roridin L2 did not produce apoptosis or toxicity in the reported PC-12 neuronal-cell or mouse intranasal models.

Mechanistic interpretation

• A yeast trichothecene study found inhibition of mitochondrial translation followed by mitochondrial membrane depolarization and fragmentation; mitochondria were the principal ROS source. This supports a class-level model in which mitochondrial injury can amplify oxidative stress and apoptotic signaling.
• However, direct measurements of mitochondrial translation, respiration, membrane potential, or morphology have not established this mechanism specifically for roridins or verrucarins. The mitochondrial-pathway interpretation for verrucarin J apoptosis remains inferential.

Clinical implications

• These findings describe cell and animal-model toxic mechanisms, often in cancer-cell systems, rather than demonstrated human exposure effects or clinical toxicity thresholds.
• Bottom line: Roridin and verrucarin congeners can induce ROS and apoptosis in particular preclinical models, with caspase/PARP activation and BCL-2 reduction supporting apoptosis for verrucarin J. Mitochondrial dysfunction is a plausible class-related explanation but is not yet directly proven for these specific macrocyclic trichothecenes.